Insmed Inc (INSM)

[Do DD]

CF,

Just relistened Q3 CC and R&R CC.

First of all: january was never mentioned as far as I could determine. In R&R it was explicitly stated that MMD trial was underway and that 'Data would be available to us early next year'.
Also during R&R CC a lot of time was spent on the current indication and the roll out of iPlex in relation to IGFD so the trial didn't seem to affect the R&R presentation in that sense at all!

To clarify my points I just relistened the Q3 CC and it seems that my topline remark came from something Geoff Allen said in the intro:

GA: topline data of the new study (he was meaning Noonan's in hindsight) in first half of 2007.

During the Q&A the following conversation ensued between Matt Osborne (LAZA) and Phil Young.

MO: what's the timing for next data for ..., MMD, ...
PY: early 07,
PY: that's for everything you just mentioned.

Philip Young is reacting to a question of Matt Osborne concerning 'next data', that's in my view something else than asking for a status update. This is confirmed in the R&R presentation!
Thus in my opinion INSM will present Data from the PhII MMD trial early '07.
Btw: enrollment takes place afaik during trials, and trials can be started long before the last patients enroll.

E.